Calluna Pharma AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 10 employees and reported revenue of 36,3 mill. kr in its latest annual filing.
In its most recent annual report (2025), Calluna Pharma AS reported revenue of 36,3 mill. kr, an increase of 35% on the year before. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of 10,1 mill. kr, and the EBITDA margin stood at -44%.
At the end of 2025, equity financed 83.9% of the balance sheet, and current assets covered short-term debt 2.2 times.
Frequently asked questions
What is the Org number of Calluna Pharma AS?
Calluna Pharma AS is registered with Brønnøysundsregistrene under Org 932255189.
What is the revenue of Calluna Pharma AS?
Calluna Pharma AS reported revenue of 36,3 mill. kr in 2025.
How many employees does Calluna Pharma AS have?
Calluna Pharma AS employs 10 people as of the latest annual report.
Who is the CEO of Calluna Pharma AS?
Mark William-Semrau Gaffney is the CEO of Calluna Pharma AS, in role since 2024.
Who is the chairman of Calluna Pharma AS?
Mark Frederick Altmeyer chairs the board of Calluna Pharma AS, in role since 2024.
Where is Calluna Pharma AS headquartered?
Calluna Pharma AS's registered address is Gaustadalléen 21, 0349 Oslo.
